December 20th, 2019
Podcast 247: Managing dyspepsia
A “network meta-analysis” (we’ll explain that) finds that “test and treat” is the best way forward in managing this common condition.
Patients, paradoxically, prefer immediate endoscopy to test-and-treat, but unless the patient has “alarm symptoms” (such as dysphagia, weight loss, and anemia), endoscopy is likely to add complications and costs without adding further benefit.
Our guest is Prof. Alexander Ford of Leeds, senior author on the guideline-affirming study in The BMJ.
Links:
Physician’s First Watch summary
NEJM Journal Watch Gastroenterology summary of 2017 joint U.S. – Canadian guideline
Podcast: Play in new window | Download
Subscribe: RSS
Categories: Dyspepsia, Endoscopy, Gastroenterology, Helicobacter pylori
Tags: alarm symptoms, Alexander Ford, guidelines, meta-analysis
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Subscribe to Clinical Conversations via Email
Archives
-
Recent Posts
- Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
- Podcast 301: Monkeypox — what to look for, how to treat
- Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
- Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
- Podcast 297: Forget about all that vitamin D testing!!
- Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
- Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
- Podcast 294: PD-1 blockade in locally advanced rectal cancer
- Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
- Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin